127 related articles for article (PubMed ID: 27061051)
1. β-ionone modulates the expression of miRNAs and genes involved in the metastatic phenotype of microdissected persistent preneoplastic lesions in rats submitted to hepatocarcinogenesis.
Furtado KS; de Oliveira Andrade F; Campos A; Rosim MP; Vargas-Mendez E; Henriques A; De Conti A; Scolastici C; Barbisan LF; Carvalho RF; Moreno FS
Mol Carcinog; 2017 Jan; 56(1):184-196. PubMed ID: 27061051
[TBL] [Abstract][Full Text] [Related]
2. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats.
Miranda MLP; Furtado KS; de Oliveira Andrade F; Heidor R; da Cruz RS; Nogueira MS; de Castro IA; Purgatto E; Barbisan LF; Moreno FS
Chem Biol Interact; 2019 Aug; 308():377-384. PubMed ID: 31150631
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA.
Cardozo MT; de Conti A; Ong TP; Scolastici C; Purgatto E; Horst MA; Bassoli BK; Moreno FS
J Nutr Biochem; 2011 Feb; 22(2):130-5. PubMed ID: 20435455
[TBL] [Abstract][Full Text] [Related]
4. β-ionone inhibits persistent preneoplastic lesions during the early promotion phase of rat hepatocarcinogenesis: TGF-α, NF-κB, and p53 as cellular targets.
Scolastici C; de Conti A; Cardozo MT; Ong TP; Purgatto E; Horst MA; Heidor R; Furtado KS; Bassoli BK; Moreno FS
Nutr Cancer; 2014; 66(2):234-41. PubMed ID: 24364727
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis.
Vieira A; Heidor R; Cardozo MT; Scolastici C; Purgatto E; Shiga TM; Barbisan LF; Ong TP; Moreno FS
Braz J Med Biol Res; 2011 Jun; 44(6):538-45. PubMed ID: 21445532
[TBL] [Abstract][Full Text] [Related]
6. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.
de Moura Espíndola R; Mazzantini RP; Ong TP; de Conti A; Heidor R; Moreno FS
Carcinogenesis; 2005 Jun; 26(6):1091-9. PubMed ID: 15718255
[TBL] [Abstract][Full Text] [Related]
7. The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation.
Romualdo GR; Prata GB; da Silva TC; Evangelista AF; Reis RM; Vinken M; Moreno FS; Cogliati B; Barbisan LF
J Nutr Biochem; 2020 Nov; 85():108479. PubMed ID: 32795656
[TBL] [Abstract][Full Text] [Related]
8. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
Pascale RM; Simile MM; Feo F
Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
[TBL] [Abstract][Full Text] [Related]
9. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
[TBL] [Abstract][Full Text] [Related]
10. Profound changes in miRNA expression during cancer initiation by aflatoxin B
Livingstone MC; Johnson NM; Roebuck BD; Kensler TW; Groopman JD
Mol Carcinog; 2017 Nov; 56(11):2382-2390. PubMed ID: 28218475
[TBL] [Abstract][Full Text] [Related]
11. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Wang B; Hsu SH; Majumder S; Kutay H; Huang W; Jacob ST; Ghoshal K
Oncogene; 2010 Mar; 29(12):1787-97. PubMed ID: 20023698
[TBL] [Abstract][Full Text] [Related]
12. Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
Chen PJ; Yeh SH; Liu WH; Lin CC; Huang HC; Chen CL; Chen DS; Chen PJ
Hepatology; 2012 Aug; 56(2):632-43. PubMed ID: 22392644
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
14. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
15. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
Petrelli A; Perra A; Schernhuber K; Cargnelutti M; Salvi A; Migliore C; Ghiso E; Benetti A; Barlati S; Ledda-Columbano GM; Portolani N; De Petro G; Columbano A; Giordano S
Oncogene; 2012 Oct; 31(42):4517-26. PubMed ID: 22249248
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
de Conti A; Kuroiwa-Trzmielina J; Horst MA; Bassoli BK; Chagas CE; Purgatto E; Cavalher FP; Camargo AA; Jordão AA; Vannucchi H; Scolastici C; Ong TP; Moreno FS
J Nutr Biochem; 2012 Aug; 23(8):860-6. PubMed ID: 21940155
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects.
Chagas CE; Bassoli BK; de Souza CA; Deminice R; Jordão Júnior AA; Paiva SA; Dagli ML; Ong TP; Moreno FS
Int J Cancer; 2011 Nov; 129(9):2073-82. PubMed ID: 21480218
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
Sukata T; Sumida K; Kushida M; Ogata K; Miyata K; Yabushita S; Uwagawa S
Toxicol Lett; 2011 Jan; 200(1-2):46-52. PubMed ID: 21035526
[TBL] [Abstract][Full Text] [Related]
19. beta-carotene inhibits persistent and stimulates remodeling gamma GT-positive preneoplastic lesions during early promotion of hepatocarcinogenesis.
Rizzi MB; Dagli ML; Jordão AA; Penteado MV; Moreno FS
Int J Vitam Nutr Res; 1997; 67(6):415-22. PubMed ID: 9433674
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
Huang GH; Shan H; Li D; Zhou B; Pang PF
Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
